160
Participants
Start Date
January 14, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Oxytocin
Patient is given oxytocin 5 IU diluted in 10 mL normal saline, administered intravenously over 1 min, followed by continuous infusion of 250 mIU/min over 4 hours.
Carbetocin
Patient is given carbetocin 100 mcg diluted in 10 mL normal saline, administered intravenously over 1 min, followed by placebo infusion for 4 hours.
RECRUITING
Mount Sinai Hospital, Toronto
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
OTHER